e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Cystic fibrosis (adults and children): risk factors and clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adults with cystic-fibrosis related diabetes have lower pulmonary function and more infections
M.C. Stam, H.W. de Valk, E.A. van de Graaf (Utrecht, Netherlands)
Source:
Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Session:
Cystic fibrosis (adults and children): risk factors and clinical problems
Session type:
Thematic Poster Session
Number:
1114
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M.C. Stam, H.W. de Valk, E.A. van de Graaf (Utrecht, Netherlands). Adults with cystic-fibrosis related diabetes have lower pulmonary function and more infections. Eur Respir J 2012; 40: Suppl. 56, 1114
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Selection of a gene panel related to pulmonary hypertension associated with respiratory diseases
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021
Screening for hickman line related infection in patients with severe pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 582s
Year: 2003
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or fiction?
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008
CF related diabetes
Source: ERS course 2015
Year: 2015
Variation in mortality from pulmonary hypertension by aetiology
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Structural lung disease, pulmonary infection and inflammation in infancy is associated with reduced spirometry at school-age in children with cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Year: 2021
Glycaemic variability indices are associated with increased pulmonary function decline in people with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring
Year: 2018
Cardiovascular comorbidities based on impaired pulmonary function in non-smoking population
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020
Outcome of pulmonary hypertension associated with respiratory disease
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Risk factors for the decline of pulmonary function among bronchiectasis patients in Japan
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018
Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy?
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
The prevalence of pulmonary hypertension and the related factors in hemodialysis patients
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept